Archive

  • Life insurance market to surge globally, says Swiss Re report

    20 November 2024

    Sector will have to navigate worrying trends in life expectancy, reinsurer warns

  • Mortality rates for young adults remain high, CMI reports

    11 October 2024
  • LCP raises questions on Dutch mortality projection model

    02 October 2024

    Methodology has significant impact on pension liabilities and risk transfer pricing

  • Apra sounds out Australia's life firms about increasing longevity products

    21 August 2024
  • Japan's insurers preparing to accept more cancer-related risks

    09 August 2024

    S&P Global Ratings says market enjoys high and stable profit margins

  • Re/insurers consider a different outcome from cancer

    08 August 2024

    Once a probable death knell, a cancer diagnosis is increasingly becoming a chronic disease, thanks to advances in testing and treatment. This has significant implications for life and health re/insurers, as David Walker reports

  • Scor shares drop 25% after warning on L&H profits

    16 July 2024

    Reserving assumptions to hit profitability of life and health business

  • Mortality is back to pre-pandemic levels, but UK insurers should be cautious about trend

    12 July 2024

    LCP's Stuart McDonald said no fall in mortality over a five-year period is very rare

  • ECA 2024: Insurers have important role in preventing mental health and metabolic risks

    07 June 2024

    Early intervention is possible thanks to data and technology, says Swiss Re's L&H pricing lead

  • Life ILS markets feel the heat from high rates

    29 May 2024

    It has been a tough period for the life insurance-linked securities (ILS) market, afflicted by higher interest rates and unexpected losses. But participants are hopeful of a revival, as Christopher Cundy reports